Key Disease Events
vascular death, death, stroke, cancer, diabetes
ADVERSE EVENTS, STROKE, DISEASE, CANCER, EVENTS, HEART FAILURE, DIABETES
After randomization, follow‐up assessments in the study were conducted at 2 months, 6 months, and every 6 months thereafter, and information was sought for serious adverse events including those resulting in hospital admissions. Key disease events considered in the present study were postrandomization MI, nonhemorrhagic stroke, urgent coronary revascularization (CRV) procedure, nonurgent CRV procedure, hospitalization for heart failure, noncoronary revascularization procedure, incident cancer, incident diabetes, vascular death, and nonvascular death. All reports of possible such events, except diabetes, were centrally adjudicated by clinicians without prior knowledge of the treatment allocations according to prespecified criteria.